FrancophonIA/ELRC3.0 huggingface dataset:
English: In lung cancer, Erbitux is expected to work in the same way as it does in its existing indications.
Slovenian: Zdravilo Erbitux naj bi pri pljučnem raku delovalo enako kot pri drugih odobrenih indikacijah.
English: Erbitux is a solution for infusion (drip into a vein) that contains the active substance cetuximab.
Slovenian: Zdravilo Erbitux je raztopina za infuzijo (kapalno infuzijo v veno), ki vsebuje zdravilno učinkovino cetuksimab.
English: Cetuximab has been designed to attach to EGFR, which can be found on the surface of some tumour cells.
Slovenian: Cetuksimab je bil zasnovan tako, da se veže na receptor za epidermalni rastni faktor, ki je na površini določenih tumorskih celic.
English: • metastatic cancer of the colon or rectum (large intestine).
Slovenian: • metastatskega raka debelega črevesa ali danke.
English: Erbitux was also expected to be used to treat ‘non-small cell' lung cancer that was advanced (had started to spread) or metastatic.
Slovenian: Zdravilo naj bi se uporabljalo tudi za zdravljenje napredovalega (ki se je začel širiti) ali metastatskega nedrobnoceličnega pljučnega raka.
English: Ref.: EMA/756630/2009 EMEA/H/C/264
Slovenian: : EMEA/756630/2009 EMEA/H/C/264
English: After five years, the marketing authorisation was renewed for a further five years.
Slovenian: Po petih letih je bilo dovoljenje za promet podaljšano za nadaljnjih pet let.
English: As the company had supplied the additional information requested, the ‘Exceptional Circumstances' ended on 10 March 2004.
Slovenian: Ko je družba predložila dodatne zahtevane podatke, je odobritev „v izjemnih okoliščinah“ prenehala veljati dne 10. marca 2004.
English: Agenerase amprenavir EPAR summary for the public
Slovenian: Agenerase amprenavir Povzetek EPAR za javnost
English: The European Commission granted a marketing authorisation valid throughout the European Union for Agenerase to Glaxo Group Limited on 20 October 2000.
Slovenian: Evropska komisija je dovoljenje za promet z zdravilom Agenerase, veljavno po vsej Evropski uniji, odobrila družbi Glaxo Group Limited dne 20. oktobra 2000.
English: Other information about Agenerase:
Slovenian: Druge informacije o zdravilu Agenerase:
English: Agenerase was originally authorised under ‘Exceptional Circumstances', because, for scientific reasons, limited information was available at the time of approval.
Slovenian: Zdravilo Agenerase je bilo prvotno odobreno „v izjemnih okoliščinah“, ker podatki zaradi znanstvenih razlogov v času odobritve niso bili na voljo.
English: It is available as cream capsules (50 and 150 mg) and as an oral solution (15 mg/ml).
Slovenian: Na voljo je v obliki kapsul krem barve (50 in 150 mg) in v obliki peroralne raztopine (15 mg/ml).
English: When the enzyme is blocked, the virus does not reproduce normally, slowing down the spread of infection.
Slovenian: Ko je encim blokiran, se virus ne more več normalno razmnoževati, kar zmanjša hitrost širjenja okužbe.
English: The Committee recommended that Agenerase be given marketing authorisation.
Slovenian: Odbor je priporočil, da se za zdravilo Agenerase odobri dovoljenje za promet.
English: This allows a lower dose of amprenavir to be used for the same effect.
Slovenian: Zato lahko uporabimo manjši odmerek amprenavirja za enak protivirusni učinek.
English: What benefit has Agenerase shown during the studies?
Slovenian: Kakšne koristi je zdravilo Agenerase izkazalo med študijami?
English: In children aged between four and 12 years and in patients who weigh less than 50 kg, the recommended dose of Agenerase depends on body weight.
Slovenian: Pri otrocih, starih od štiri do 12 let, in bolnikih, ki tehtajo manj kot 50 kg, je višina priporočenega odmerka zdravila Agenerase odvisna od telesne mase bolnika.
English: If ritonavir is not used, Agenerase is taken at a higher dose (1,200 mg twice a day).
Slovenian: Če bolnik ne prejema ritonavirja, je odmerek zdravila Agenerase višji (1 200 mg dvakrat na dan).
English: The recommended dose of Agenerase for patients over 12 years of age is 600 mg twice a day, taken with 100 mg ritonavir twice a day and with other antiviral medicines.
Slovenian: Priporočeni odmerek zdravila Agenerase za bolnike, starejše od 12 let, je 600 mg dvakrat na dan skupaj s 100 mg ritonavirja dvakrat na dan in drugimi protivirusnimi zdravili.
English: Agenerase, taken in combination with other antiviral medicines, reduces the amount of HIV in the blood and keeps it at a low level.
Slovenian: Zdravilo Agenerase v kombinaciji z drugimi protivirusnimi zdravili zniža količino virusov HIV v krvi in jo zadržuje na nizki ravni.
English: The main measures of effectiveness were the number of patients with undetectable levels of HIV in the blood (viral load) and the change in viral load after treatment.
Slovenian: Glavni merili učinkovitosti sta bili število bolnikov z nezaznavno ravnjo virusa HIV v krvi (virusno obremenitvijo) in sprememba virusne obremenitve po zdravljenju.
English: What is the risk associated with Agenerase?
Slovenian: Kakšna tveganja so povezana z zdravilom Agenerase?
English: Agenerase does not cure HIV infection or AIDS, but it may delay the damage to the immune system and the development of infections and diseases associated with AIDS.
Slovenian: Zdravilo Agenerase ne zdravi okužbe z virusom HIV ali aidsa lahko pa podaljša čas do pojava poškodbe imunskega sistema ter razvoja okužb in bolezni, ki so povezane z aidsom.
English: Agenerase is a medicine that contains the active substance amprenavir.
Slovenian: Agenerase je zdravilo, ki vsebuje zdravilno učinkovino amprenavir.
English: See the Package Leaflet for the full list of these medicines.
Slovenian: Za celoten seznam teh zdravil glejte navodilo za uporabo.
English: The oral solution is for patients who cannot swallow the capsules but it cannot be given with ritonavir.
Slovenian: Peroralna raztopina je namenjena bolnikom, ki ne morejo pogoltniti kapsul, vendar se ne sme dajati skupaj z ritonavirjem.
English: Of these, 43 had HIV that was resistant to four other protease inhibitors.
Slovenian: Med temi bolniki jih je 43 bilo okuženih z virusom HIV, ki je bil odporen na štiri druge zaviralce proteaz.
English: Agenerase is used in combination with other antiviral medicines to treat patients over four years of age who are infected with human immunodeficiency virus type 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS).
Slovenian: Zdravilo Agenerase se uporablja v kombinaciji z drugimi protivirusnimi zdravili za zdravljenje bolnikov, starejših od štirih let, ki so okuženih z virusom humane imunske pomanjkljivosti tipa 1 (HIV-1), ki povzroča sindrom pridobljene imunske pomanjkljivosti (aids).
English: It slows down the rate at which amprenavir is broken down, increasing the levels of amprenavir in the blood.
Slovenian: Učinkuje tako, da upočasni hitrost razgrajevanja amprenavirja in s tem zviša njegove ravni v krvi.
English: Doctors should prescribe Agenerase after they have looked at the antiviral medicines the patient has taken before and the likelihood that the virus will respond to the medicine.
Slovenian: Preden zdravnik predpiše zdravilo Agenerase, se mora seznaniti z vsemi protivirusnimi zdravili, ki jih je bolnik prejemal pred tem, in oceniti verjetnost, da se bo virus odzval na zdravilo.
English: Treatment with Agenerase should be started by a doctor who has experience in the management of HIV infection.
Slovenian: Zdravljenje z zdravilom Agenerase lahko uvede le zdravnik, ki ima izkušnje z zdravljenjem okužbe z virusom HIV.
English: Agenerase should not be used in people who may be hypersensitive (allergic) to amprenavir or any of the other ingredients.
Slovenian: Zdravila Agenerase ne smejo uporabljati osebe, ki utegnejo biti preobčutljive za (alergične na) amprenavir ali katerokoli drugo sestavino zdravila.
English: The Committee for Medicinal Products for Human Use (CHMP) decided that Agenerase benefits are greater than its risks, but noted that the benefit of Agenerase taken with ritonavir has not been demonstrated in patients who have not taken protease inhibitors in the past.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) je zaključil, da so koristi zdravila Agenerase večje od z njim povezanih tveganj, vendar je opozoril, da korist zdravila Agenerase v kombinacji z ritonavirjem ni bila dokazana pri bolnikih, ki se v preteklosti še niso zdravili z zaviralci proteaz.
English: In the studies of adults who had not previously taken protease inhibitors, Agenerase taken without ritonavir was more effective than placebo but less effective than indinavir.
Slovenian: V študijah na odraslih, ki predhodno niso jemali zaviralcev proteaz, je bilo zdravilo Agenerase brez kombinacije ritonavirja učinkovitejše od placeba, vendar manj učinkovito od indinavirja.
English: For the full list of all side effects reported with Agenerase, see the Package Leaflet.
Slovenian: Za celoten seznam vseh neželenih učinkov, o katerih so poročali pri uporabi zdravila Agenerase, glejte navodilo za uporabo.
English: Because amprenavir is less easily absorbed with the oral solution than with the capsules, the two formulations are not interchangeable on a milligram-for-milligram basis.
Slovenian: Ker se amprenavir v obliki peroralne raztopine po zaužitju ne absorbira tako lahko kot amprenavir v obliki kapsul, ti obliki zdravila nista medsebojno zamenljivi po načelu „miligram za miligram“.
English: In adults, Agenerase capsules are usually given with low-dose ritonavir (another antiviral medicine).
Slovenian: Odraslim se morajo kapsule zdravila Agenerase praviloma dajati skupaj z nizkim odmerkom ritonavirja (drugega protivirusnega zdravila).
English: As with other anti-HIV medicines, patients taking Agenerase may be at risk of lipodystrophy (changes in the distribution of body fat), osteonecrosis (death of bone tissue) or immune reactivation syndrome (symptoms of infection caused by the recovering immune system).
Slovenian: Enako kot pri drugih zdravilih proti virusu HIV lahko pride tudi pri bolnikih, ki jemljejo zdravilo Agenerase, do lipodistrofije (sprememb v porazdelitvi telesnega maščevja), osteonekroze (odmiranja kostnega tkiva) ali sindroma imunske reaktivacije (simptomov okužbe, ki jih povzroči imunski sistem med okrevanjem).
English: Agenerase should only be used in patients who have previously been treated with the same type of medicine as Agenerase (protease inhibitors).
Slovenian: Zdravilo Agenerase smejo uporabljati le tisti bolniki, ki so že bili predhodno zdravljeni z isto vrsto zdravila, kot je zdravilo Agenerase (zaviralci proteaz).
English: The most common side effects with Agenerase (seen in more than 1 patient in 10) are hypercholesterolaemia (high blood cholesterol levels), headache, diarrhoea, flatulence (gas), nausea (feeling sick), vomiting, rash and fatigue (tiredness).
Slovenian: Najpogostejši neželeni učinki zdravila Agenerase (opaženi pri več 1 bolniku od 10) so hiperholesterolemija (visoke koncentracije holesterola v krvi), glavobol, driska, flatulenca (vetrovi), navzeja (slabost), bruhanje, izpuščaji in utrujenost.
English: Why has Agenerase been approved?
Slovenian: Zakaj je bilo zdravilo Agenerase odobreno?
English: Agenerase without ritonavir has also been compared with placebo (a dummy treatment) and with invirase (another protease inhibitor) in 736 HIV-infected adults who had not previously been treated with protease inhibitors.
Slovenian: Zdravilo Agenerase brez dodanega ritonavirja so primerjali tudi s placebom (zdravilom brez zdravilne učinkovine) in invirazo (drugim zaviralcem proteaz) pri 736 odraslih ljudeh, okuženih z virusom HIV, ki predhodno še niso bili zdravljeni z zaviralci proteaze.
English: In adults who had taken protease inhibitors in the past, Agenerase boosted with ritonavir was as effective as other protease inhibitors in reducing viral loads after 16 weeks of treatment: around two thirds of the patients in both groups had viral loads below 400 copies/ml.
Slovenian: Zdravilo Agenerase, ojačeno z ritonavirjem, je bilo pri odraslih, ki so v preteklosti jemali zaviralce proteaz, po 16 tednih zdravljenja enako učinkovito pri nižanju virusne obremenitve kot drugi zaviralci proteaz: okoli dve tretjini bolnikov v obeh skupinah je imelo virusno obremenitev pod 400 kopijami/ml.
English: Agenerase must not be used in patients who are taking St John's wort (a herbal preparation used to treat depression) or medicines that are broken down in the same way as Agenerase and are harmful at high levels in the blood.
Slovenian: Zdravila Agenerase ne smejo uporabljati bolniki, ki jemljejo šentjanževko (rastlinski pripravek za zdravljenje depresije) ali zdravila, ki se presnavljajo enako kot zdravilo Agenerase in so pri visokih ravneh v krvi škodljiva.
English: The full EPAR for Agenerase can be found here.
Slovenian: Celotno evropsko javno poročilo o oceni zdravila (EPAR) za zdravilo Agenerase je na voljo tukaj.
English: The active substance in Agenerase, amprenavir, is a protease inhibitor.
Slovenian: Zdravilna učinkovina zdravila Agenerase, amprenavir, spada med zaviralce proteaz.
English: Agenerase boosted with ritonavir must not be taken by patients who have severe problems with their liver, or by patients taking rifampicin (used to treat tuberculosis) or medicines that are broken down in the same way as ritonavir, such as flecainide and propafenone (used to correct irregular heartbeat).
Slovenian: Zdravila Agenerase v kombinaciji z ritonavirjem, ki okrepi učinek zdravila, prav tako ne smejo uporabljati bolniki, ki imajo hude težave z jetri ali jemljejo rifampicin (zdravilo za zdravljenje tuberkuloze) oziroma zdravila, ki se presnavljajo enako kot ritonavir, kot sta flekainid in propafenon (zdravilo za uravnavanje nerednega srčnega ritma).
English: How has Agenerase been studied?
Slovenian: Kako je bilo zdravilo Agenerase raziskano?
English: Patients who have problems with their liver may be at an elevated risk of liver damage when taking Agenerase.
Slovenian: Pri bolnikih s težavami z jetri obstaja pri jemanju zdravila Agenerase povečano tveganje za poškodbe jeter.
English: Taking Agenerase with ritonavir should be avoided in children.
Slovenian: Pri otrocih bi se morali izogibati sočasni uporabi zdravila Agenerase in ritonavirja.
English: The dose of Agenerase should be reduced in patients who have problems with their liver, and it should be taken without ritonavir by patients who have severe liver problems.
Slovenian: Odmerek zdravila Agenerase je treba zmanjšati pri bolnikih s težavami z jetri, pri bolnikih s hudimi težavami z jetri pa se mora zdravilo Agenerase uporabljati brez ritonavirja.
English: What is Agenerase used for?
Slovenian: Za kaj se zdravilo Agenerase uporablja?
English: Agenerase without ritonavir has also been studied in 268 HIV-infected children and adolescents aged between six months and 18 years, all of whom had previously taken treatment for HIV infection, and 135 of whom had been treated with protease inhibitors.
Slovenian: Zdravilo Agenerase brez dodanega ritonavirja so raziskali tudi pri 268 otrocih in mladostnikih, okuženih z virusom HIV, ki so bili stari od šest mesecev do 18 let.
English: How is Agenerase used?
Slovenian: Kako se zdravilo Agenerase uporablja?
English: What is Agenerase?
Slovenian: Kaj je zdravilo Agenerase?
English: Agenerase reduced viral loads in children and adolescents, although very few of those who had taken protease inhibitors in the past responded to treatment and there were very few children aged below four years.
Slovenian: Pri bolnikih z virusom HIV, odpornim na štiri druge zaviralce proteaz, so tisti, ki so jemali kombinacijo zdravila Agenerase in ritonavirja, po štirih tednih pokazali večje znižanje virusne obremenitve kot tisti, ki so še naprej jemali svoje dotedanje zaviralce proteaz: zdravilo Agenerase je znižalo virusno obremenitev pri otrocih in mladostnikih, vendar se je na zdravljenje odzvalo majhno število tistih, ki so v preteklosti že jemali zaviralce proteaz, med njimi pa je bilo zelo majhno število otrok, mlajših od štirih let.
English: Agenerase boosted with low-dose ritonavir has been compared with other protease inhibitors in 206 adults who had taken protease inhibitors in the past.
Slovenian: Pri 206 odraslih, ki so v preteklosti že prejemali zaviralce proteaz, so učinkovitost zdravila Agenerase, ojačenega z nizkimi odmerki ritonavirja, primerjali tudi z učinkovitostjo drugih zaviralcev proteaz.
English: How does Agenerase work?
Slovenian: Kako zdravilo Agenerase deluje?
English: B 1930 Zaventem Belgium
Slovenian: B 1930 Zaventem Belgija
English: If you are an elderly patient (over 65 years of age), you should take Lyrica normally except if you have problems with your kidneys.
Slovenian: Če ste starejši bolnik (nad 65 let), lahko jemljete zdravilo Lyrica normalno, razen če imate težave z ledvicami.
English: Do not use this medicine after the expiry date which is stated on the carton or bottle.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli ali plastenki.
English: Lyrica should not be used during pregnancy unless clearly necessary (if the benefit to the mother clearly outweighs the potential risk to the foetus).
Slovenian: Zdravila Lyrica se ne sme uporabljati med nosečnostjo, razen če je nujno potrebno (če koristi za mater jasno prevladajo nad možnim tveganjem za plod).
English: Date of first authorisation: 06 July 2004 Date of latest renewal: 06 July 2009
Slovenian: Datum prve odobritve: 6. julij 2004 Datum zadnjega podaljšanja: 6. julij 2009
English: Lyrica is not intended to be used alone, but should always be used in combination with other anti-epileptic treatment.
Slovenian: Zdravilo Lyrica ni namenjeno temu, da bi ga jemali samo, temveč ga je vedno treba uporabljati v kombinaciji z drugimi zdravili proti epilepsiji.
English: Lyrica and certain other medicines may influence each other (interaction).
Slovenian: Zdravilo Lyrica in določena druga zdravila imajo lahko medsebojno delovanje (interakcije).
English: female for mol/l)
Slovenian: za mol/l)
English: * Alanine aminotransferase increased (ALT) and aspartate aminotransferase increased (AST).
Slovenian: * zvišanje alanin aminotransferaze (ALT) in aspartat aminotransferaze (AST)
English: Lyrica oral solution contains small amounts of ethanol (alcohol), less than 100 mg/ml.
Slovenian: Zdravilo Lyrica peroralna raztopina vsebuje majhne količine etanola (alkohol), in sicer manj kot 100 mg/ml.
English: The body is also marked with a black band.
Slovenian: Telo je poleg tega označeno s črno črto.
English: Note: Steps 4-7 may need to be repeated up to three times to obtain the total dose (Table 1).
Slovenian: Opomba: Korake 4 do 7 morate morda ponoviti do trikrat, da boste prejeli ustrezni celotni odmerek (Pregledica 1).
English: If you have the impression that the effect of Lyrica is too strong or too weak, talk to your doctor or pharmacist.
Slovenian: Če imate občutek, da je učinek zdravila Lyrica premočan ali prešibak, se posvetujte z zdravnikom ali farmacevtom.
English: What Lyrica is and what it is used for
Slovenian: Kaj je zdravilo Lyrica in za kaj ga uporabljamo
English: Very common: may affect more than 1 in 10 people Dizziness, drowsiness, headache.
Slovenian: Zelo pogosti: pojavijo se lahko pri več kot 1 od 10 bolnikov omotica, zaspanost, glavobol
English: The capsule body is marked with a black band.
Slovenian: Telo kapsule je označeno s črno črto.
English: weight x
Slovenian: masa x
English: Do not take Lyrica: If you are allergic to pregabalin or any of the other ingredients of this medicine (listed in section 6).
Slovenian: Ne jemljite zdravila Lyrica: • če ste alergični na pregabalin ali katerokoli sestavino tega zdravila (navedeno v poglavju 6).
English: In table 2 below all adverse reactions, which occurred at an incidence greater than placebo and in more than one patient, are listed by class and frequency (very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from the available data).
Slovenian: V spodnji preglednici 2 so po organskih sistemih in pogostnosti navedeni vsi neželeni učinki, ki so se pojavili pri več kot enem bolniku in z incidenco, večjo kot pri placebu (zelo pogosti (≥ 1/10); pogosti (≥ 1/100 do < 1/10); občasni (≥ 1/1.000 do < 1/100); redki (≥ 1/10.000 do < 1/1.000); zelo redki (< 1/10.000); neznana (ni mogoče oceniti iz razpoložljivih podatkov)).
English: The safety and efficacy of Lyrica in children below the age of 12 years and in adolescents (12-17 years of age) have not been established.
Slovenian: Varnost in učinkovitost zdravila Lyrica pri otrocih, starih do 12 let, in pri mladostnikih (12-17 let) nista bili dokazani.
English: This product contains lactose monohydrate: see the package leaflet for further information.
Slovenian: To zdravilo vsebuje laktozo monohidrat: za nadaljnje informacije glejte navodilo za uporabo.
English: Concomitant use with opioids
Slovenian: Sočasna uporaba z opioidi
English: Central nervous system influencing medical products Pregabalin may potentiate the effects of ethanol and lorazepam.
Slovenian: Zdravila, ki vplivajo na osrednji živčni sistem Pregabalin lahko stopnjuje učinke etanola in lorazepama.
English: Using the oral syringe, first withdraw 5 ml and empty contents of syringe directly into the mouth, then refill the oral syringe with 2.5 ml and empty the remaining contents into the mouth.]
Slovenian: Z uporabo peroralne brizge najprej odvzemite 5 ml in izpraznite vsebino brizge neposredno v vaša usta, nato napolnite brizgo do 2,5 ml in izpraznite vsebino brizge v usta.]
English: • Your doctor will tell you to take Lyrica either twice or three times a day.
Slovenian: • Zdravilo Lyrica morate vzeti dvakrat ali trikrat na dan.
English: It is important to take your Lyrica capsules regularly at the same time each day.
Slovenian: Pomembno je, da kapsule Lyrica jemljete redno, vsak dan ob istem času.
English: These symptoms may occur more commonly or severely if you have been taking Lyrica for a longer period of time.
Slovenian: Ti znaki se lahko pojavljajo bolj pogosto in z večjo izrazitostjo, če ste zdravilo Lyrica jemali daljši čas.
English: Pfizer Service Company, Hoge Wei 10, B1930 Zaventem, Belgium
Slovenian: Izdelovalec: Pfizer Service Company, Hoge Wei 10, B1930 Zaventem, Belgija
English: The degree of dizziness, sleepiness and decreased concentration may be increased if Lyrica is taken together with medicines containing:
Slovenian: Omotica, zaspanost ali zmanjšanje sposobnosti koncentracije se lahko stopnjujejo, če zdravilo Lyrica vzamemo skupaj z zdravili, ki vsebujejo:
English: • Lyrica may cause blurring or loss of vision, or other changes in eyesight, many of which are temporary.
Slovenian: • Uporaba zdravila Lyrica lahko povzroči zamegljenost ali izgubo vida ali druge spremembe vida, med katerimi so mnoge začasne.
English: Not required
Slovenian: Ni potrebno
English: patients)
Slovenian: bolnice)
English: Continue taking Lyrica until your doctor tells you to stop.
Slovenian: Zdravilo Lyrica jemljite, dokler vam zdravnik ne naroči, da nehajte.
English: You should take Lyrica in addition to your current treatment.
Slovenian: Zdravilo Lyrica morate jemati poleg trenutno uporabljanih zdravil.
English: Lyrica should not be taken during pregnancy or when breast-feeding, unless you are told otherwise by your doctor.
Slovenian: Zdravila Lyrica ne smete uporabljati med nosečnostjo ali dojenjem, razen če vam tako svetuje zdravnik.
English: [For example, a 150 mg (7.5 ml) dose will require two withdrawals from the bottle to achieve the entire dose.
Slovenian: [Primer: za odmerek 150 mg (7,5 ml) bosta potrebna dva odvzema iz plastenke, da bi dosegli celoten odmerek.
English: creatinine serum
Slovenian: serumu kreatinin
English: Your doctor will prescribe Lyrica for you to help treat your epilepsy when your current treatment is not controlling your condition.
Slovenian: Zdravnik bo predpisal zdravilo Lyrica kot pomoč za zdravljenje epilepsije, če zdravila, ki jih trenutno uporabljate, bolezni ne obvladujejo.